On-demand treatment of hereditary angioedema attacks: patient-reported utilization, barriers, and outcomes.

Autor: Christiansen S; University of California San Diego, La Jolla, CA, USA. Electronic address: scchristiansen@health.ucsd.edu., O'Connor M; Integrative Allergy & Immunology Care Allergy, Asthma, & Immunology Research Institute., Craig T; Penn State Health, Hershey, Pennsylvania, Vinmec International Hospital, Hanoi, Vietnam., Radojicic C; Duke University School of Medicine, Durham, NC, USA., Wedner HJ; Washington University School of Medicine, St Louis, MO, USA., Danese S; Outcomes Insights, Agoura Hills, CA, USA., Ulloa J; Outcomes Insights, Agoura Hills, CA, USA., Desai V; KalVista Pharmaceuticals, Cambridge, MA, USA., Utter C; KalVista Pharmaceuticals, Cambridge, MA, USA., Andriotti T; KalVista Pharmaceuticals, Cambridge, MA, USA., Audhya P; KalVista Pharmaceuticals, Cambridge, MA, USA., Busse P; The Mount Sinai Hospital, New York, NY, USA.

Publikováno v: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2024 Dec 16. Date of Electronic Publication: 2024 Dec 16.

Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas.

Autor: Radojicic C; From the Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Duke University, Durham, North Carolina., Anderson J; Division of Pulmonary Allergy, Critical Care in Sleep Medicine, Department of Internal Medicine, University of Alabama, Birmingham, Alabama, and.

Publikováno v: Allergy and asthma proceedings [Allergy Asthma Proc] 2024 May 01; Vol. 45 (3), pp. 147-157.

P52 Burden of the Untreated Attacks and Its Impact on Social, Mental and Physical Health

Autor: Radojicic, C., Busse, P., O'Connor, M., Danese, S., Ulloa, J., Desai, V., Andriotti, T., Audhya, P., Christiansen, S.

Publikováno v: In Value in Health June 2024 27(6) Supplement:S12-S12

Efficacy of a Clinical Decision Rule to Enable Direct Oral Challenge in Patients With Low-Risk Penicillin Allergy: The PALACE Randomized Clinical Trial.

Autor: Copaescu AM; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.; The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia., Vogrin S; Department of Medicine, St Vincent's Hospital, The University of Melbourne, Melbourne, Victoria, Australia., James F; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Chua KYL; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Rose MT; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia.; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., De Luca J; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Medicine, Austin Health, The University of Melbourne, Melbourne, Victoria, Australia., Waldron J; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Awad A; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Godsell J; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Clinical Immunology and Allergy, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Mitri E; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia., Lambros B; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Douglas A; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; The National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Youcef Khoudja R; The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Isabwe GAC; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.; The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Genest G; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.; The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Fein M; Division of Allergy and Clinical Immunology, Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Radojicic C; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Collier A; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Lugar P; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., Stone C; Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee., Ben-Shoshan M; The Research Institute of the McGill University Health Centre, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.; Division of Allergy, Immunology and Dermatology, Montreal Children's Hospital, McGill University Health Centre McGill University, Montreal, Quebec, Canada., Turner NA; Department of Infectious Diseases, Duke University Medical Center, Durham, North Carolina., Holmes NE; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia., Phillips EJ; Center for Drug Safety and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia, Australia., Trubiano JA; Centre for Antibiotic Allergy and Research, Department of Infectious Diseases, Austin Health, Heidelberg, Victoria, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Victoria, Australia.

Publikováno v: JAMA internal medicine [JAMA Intern Med] 2023 Sep 01; Vol. 183 (9), pp. 944-952.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.